Mary is the Chief Investment Officer of Misha Investments and CFO & Director of a biotech company. She has extensive experience in investing and capital markets. Over the past 20 years, she has structured, placed, or invested in structured products, bank loans, junior capital, high yield, early-stage companies, real estate, and private equity funds.
Prior to Misha Investments, Mary worked for 3 years at Four M Investments where she was Chief Investment Officer and Chief Financial Officer for the family office. She was responsible for cash management, tax planning, and investments in fixed income, equity, MLPs, Preferreds, real estate, and funds. Prior to Four M Investments, Mary worked as a Managing Director at GE Capital Markets for 9 years where she was responsible for establishing and running the junior capital business and helped set up the unitranche fund with Allied Capital (later sold to Ares). She built deep relationships with banks, private equity funds, hedge funds, distressed funds, mezzanine funds, insurance companies, BDCs, and other alternate sources of capital. She placed over $13 billion in volume and 150+ deals, which included acquisition financing, refinancing, recapitalizations, restructurings (Radnet, CCA), DIPS (Delta DIP), EXITS (Delta, US Air), amendments, and trading of loans.